mRNA |
Topotecan |
CCLE |
pan-cancer |
AAC |
0.16 |
0.0002 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
mRNA |
brivanib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0003 |
mRNA |
BRD-K70511574 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0003 |
mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0004 |
mRNA |
1S,3R-RSL-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0004 |
mRNA |
BRD-K94991378 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0004 |
mRNA |
(5Z)-7-Oxozeaenol |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.0004 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0004 |